A lipidomic analysis approach to evaluate the response to cholesterol-lowering food intake

Metabolomics

Volumn 8, Issue 5, 2012, Pages 894-906

  Szymańska, Ewa ^a,b   van Dorsten, Ferdinand A ^a,c   Troost, Jorne ^a,d   Paliukhovich, Iryna ^a,d   van Velzen, Ewoud J J ^a,b,c   Hendriks, Margriet M W B ^a,e   Trautwein, Elke A ^c   van Duynhoven, John P M ^a,c,f   Vreeken, Rob J ^a,d   Smilde, Age K ^a,b  

^a NETHERLANDS METABOLOMICS CENTRE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Data analysis; LDL cholesterol; Linear mixed models; Lipidomics; Lipoproteins; Multilevel PLS DA; Plant sterols

Indexed keywords

CHOLESTEROL; CHOLESTEROL ARACHIDONATE; CHOLESTEROL ESTER; FAT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYSOPHOSPHATIDYLCHOLINE; PHYTOSTEROL; PLACEBO; SPHINGOMYELIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; YOGHURT;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DOUBLE BLIND PROCEDURE; FAT INTAKE; FOOD COMPOSITION; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPIDOMICS; MULTIVARIATE ANALYSIS; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; UNIVARIATE ANALYSIS; VOLUNTEER;

EID: 84867197436     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-011-0384-2     Document Type: Article

References (45)

1. Bergheanu, S. C., Reijmers, T., Zwinderman, A. H., et al. (2008). Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: Investigating differential effects among statins. Current Medical Research and Opinion, 24, 2477-2487.
2. Brennan, L. (2008). Session 2: Personalised nutrition Metabolomic applications in nutritional research. Proceedings of the Nutrition Society, 67, 404.
3. Brüll, F., Mensink, R. P., & Plat, J. (2009). Plant sterols: Functional lipids in immune function and inflammation? Clinical Lipidology, 4, 355-365.
4. Chow, S. C., Shao, J., & Wang, H. (2007). Sample size calculations in clinical research. New York: CRC Press.
5. de Jong, A., Plat, J., & Mensink, R. P. (2003). Metabolic effects of plant sterols and stanols (review). Journal of Nutritional Biochemistry, 14, 362-369.
6. Demonty, I., Ras, R. T., van der Knaap, H. C. M., et al. (2009). Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. Journal of Nutrition, 139, 271-284.
7. Doornboos, A. M. E., Meynen, E. M., Duchateau, G. S. M. J. E., van der Knaap, H. C. M., & Trautwein, E. A. (2005). Intake occasion affects the serum cholesterol lowering of a plant sterol-enriched single-dose yoghurt drink in mildly hypercholesterolaemic subjects. European Journal of Clinical Nutrition, 60, 325-333.
8. Ekroos, K., Jänis, M., Tarasov, K., Hurme, R., & Laaksonen, R. (2010). Lipidomics: A tool for studies of atherosclerosis. Current Atherosclerosis Reports, 12, 273-281; 281.
9. Hidaka, H., Hanyu, N., Sugano, M., Kawasaki, K., Yamauchi, K., & Katsuyama, T. (2007). Analysis of human serum lipoprotein lipid composition using MALDI-TOF mass spectrometry. Annals of Clinical and Laboratory Science, 37, 213-221.
10. Hu, C., van Dommelen, J., van der Heijden, R., et al. (2008). RPLC-Ion-Trap-FTMS method for lipid profiling of plasma: Method validation and application to p53 mutant mouse model. Journal of Proteome Research, 7, 4982-4991.
11. Hunter, P. (2009). Reading the metabolic fine print. EMBO Reports, 10, 20-23.
12. Jiang, X. C., Paultre, F., Pearson, T. A., et al. (2000). Plasma sphingomyelin level as a risk factor for coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 2614-2618.
13. Kaddurah-Daouk, R., Baillie, R. A., Zhu, H., et al. (2010). Lipidomic analysis of variation in response to simvastatin in the cholesterol and pharmacogenetics study. Metabolomics, 6, 191-201.
14. Katan, M. B., Grundy, S. M., Jones, P., Law, M., Miettinen, T., & Paoletti, R. (2003). Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clinic Proceedings, 78, 965-978.
15. Kekkonen, R. A., Sysi-Aho, M., Seppännen-Laakso, T., et al. (2008). Effect of probiotic Lactobacillus rhamnosus GG intervention on global serum lipidomic profiles in healthy adults. World Journal of Gastroenterology, 14, 3188-3194.
16. Kontush, A., & Chapman, M. (2010). Lipidomics as a tool for the study of lipoprotein metabolism. Current Atherosclerosis Reports, 12, 194-201; 201.
17. Laaksonen, R., Katajamaa, M., Paiva, H., et al. (2006). A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. PLoS ONE, 1, e97.
18. Lankinen, M., Schwab, U., Erkkila, A., et al. (2009). Fatty fish intake decreases lipids related to inflammation and insulin signaling-a lipidomics approach. PLoS ONE, 4, e5258.
19. Lodge, J. K. (2010). Symposium 2: Modern approaches to nutritional research challenges targeted and non-targeted approaches for metabolite profiling in nutritional research. Proceedings of the Nutrition Society, 69, 95-102.
20. Müller, M., & Kersten, S. (2003). Nutrigenomics: Goals and strategies. Nature Reviews, 4, 315-322.
21. Nilsson, A., & Duan, R. D. (2006). Absorption and lipoprotein transport of sphingomyelin. Journal of Lipid Research, 47, 154-171.
22. Nixon, G. F. (2009). Sphingolipids in inflammation: Pathological implications and potential therapeutic targets. British Journal of Pharmacology, 158, 982-993.
23. Orešič, M. (2009a). Bioinformatics and computational approaches applicable to lipidomics. European Journal of Lipid Science and Technology, 111, 99-106.
24. Orešič, M. (2009b). Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutrition, Metabolism and Cardiovascular Diseases, 19, 816-824.
25. Psychogios, N., Hau, D. D., Peng, J., et al. (2011). The human serum metabolome. PLoS ONE, e16957.
26. Rajpathak, S. N., Xue, X., Wassertheil-Smoller, S., et al. (in press). Effect of long term low-fat dietary intervention on change in hemostatic factors: Results from the Women's Health Initiative. Nutrition, Metabolism and Cardiovascular Diseases. doi: 10. 1016/j. numecd. 2010. 07. 002.
27. Ramstedt, B., & Slotte, J. P. (2006). Sphingolipids and the formation of sterol-enriched ordered membrane domains. Biochimica et Biophysica Acta, 1758, 1945-1956.
28. Ridgway, N. D. (2000). Interactions between metabolism and intracellular distribution of cholesterol and sphingomyelin. Biochimica et Biophysica Acta, 1484, 129-141.
29. Romaguera, D., Norat, T., Vergnaud, A., et al. (2010). Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project. The American Journal of Clinical Nutrition, 92, 912-921.
30. Rubingh, C. M., van Erk, M. J., Wopereis, S., et al. (2011). Discovery of subtle effects in a human intervention trial through multilevel modeling. Chemometrics and Intelligent Laboratory Systems, 106, 108-114.
31. Schlitt, A., Blankenberg, S., Yan, D., et al. (2006). Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease. Nutrition & Metabolism (Lond), 3, 5.
32. Schmitz, G., & Ruebsaamen, K. (2010). Metabolism and atherogenic disease association of lysophosphatidylcholine. Atherosclerosis, 208, 10-18.
33. Schwab, U., Seppännen-Laakso, T., Yetukuri, L., Ågren, J., et al. (2008). Triacylglycerol fatty acid composition in diet-induced weight loss in subjects with abnormal glucose metabolism-The GENOBIN study. PLoS ONE, 3, e2630.
34. Smit, S., van Breemen, M. J., Hoefsloot, H. C. J., Smilde, A. K., Aerts, J. M. F. G., & de Koster, C. G. (2007). Assessing the statistical validity of proteomics based biomarkers. Analytica Chimica Acta, 592, 210-217.
35. Stegemann, C., Drozdov, I., Shalhoub, J., et al. (2011). Comparative lipidomics profiling of human atherosclerotic plaques/clinical perspective. Circulation: Cardiovascular Genetics., 4, 232-242.
36. Sysi-Aho, M., Vehtari, A., Velagapudi, V. R., et al. (2007). Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles. Bioinformatics, 23, i519-i528.
37. Szymańska, E., Markuszewski, M. J., Capron, X., et al. (2007). Increasing conclusiveness of metabonomic studies by cheminformatic preprocessing of capillary electrophoretic data on urinary nucleoside profiles. Journal of Pharmaceutical and Biomedical Analysis, 43, 413-420.
38. Thissen, U., Wopereis, S., van den Berg, S. A. A., et al. (2009). Improving the analysis of designed studies by combining statistical modelling with study design information. BMC Bioinformatics, 10, 52.
39. Trautwein, E. A., Duchateau, G. S. M. J., Lin, Y., Mel'nikov, S. M., Molhuizen, H. O. F., & Ntanios, F. Y. (2003). Proposed mechanisms of cholesterol-lowering action of plant sterols. European Journal of Lipid Science and Technology, 105, 171-185.
40. van Dorsten, F. A., Daykin, C. A., Mulder, T. P. J., & van Duynhoven, J. P. M. (2006). Metabonomics approach to determine metabolic differences between green tea and black tea consumption. Journal of Agricultural and Food Chemistry, 54, 6929-6938.
41. van Velzen, E. J. J., Westerhuis, J. A., van Duynhoven, J. P. M., et al. (2008). Multilevel data analysis of a crossover designed human nutritional intervention study. Journal of Proteome Research, 7, 4483-4491.
42. Walsh, M. C., Brennan, L., Malthouse, J. P. G., Roche, H. M., & Gibney, M. J. (2006). Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. The American Journal of Clinical Nutrition, 84, 531-539.
43. Wiesner, P., Leidl, K., Boettcher, A., Schmitz, G., & Liebisch, G. (2009). Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry. Journal of Lipid Research, 50, 574-585.
44. Yetukuri, L., Katajamaa, M., Medina-Gomez, G., Seppännen-Laakso, T., Vidal-Puig, A., & Orešič, M. (2007). Bioinformatics strategies for lipidomics analysis: Characterization of obesity related hepatic steatosis. BMC Systems Biology, 1, 12.
45. Yetukuri, L., Söderlund, S., Koivuniemi, A., et al. (2010). Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. Journal of Lipid Research, 51, 2341-2351.